21.06.2024
О. В. Воробьева; Н. Н. Шиндряева; В. В. Фатеева
of COVID-19.
Objective: to investigate the impact of COVID-19 on the dynamics of cognitive status
19.12.2022
Н. Н. Коберская; Ф. А. Рощин
In elderly patients with COVID-19 cognitive functions decline; it has been suggested that SARS-CoV
24.08.2022
Ю. А. Старчина; О. В. Косивцова
COVID-19, memantine (akatinol memantine) is recommended.
14.08.2021
А. Н. Боголепова; Н. А. Осиновская; Е. А. Коваленко; Е. В. Махнович
Post-COVID syndrome can develop in all patients who have had COVID-19, regardless of the disease
23.04.2021
В. А. Головачева; Г. Р. Табеева; И. В. Кузнецов
2019 (COVID-19). Among the pathogenetic mechanisms, the neurotropicity of the SARS- CoV-2 virus
22.04.2021
В. А. Куташов
) with COVID-19 and CI participated in the study. One-half of the included participants – 222 patients (70 men
18.02.2021
Т. М. Остроумова; П. А. Черноусов; И. В. Кузнецов
The neurological manifestations of the novel coronavirus COVID-19 infection caused by SARS-CoV-2
17.02.2021
В. В. Ковальчук
COVID-19 worsens the course of cerebrovascular diseases (CVD), including chronic cerebral
